TMCnet - World's Largest Communications and Technology Community



CRDC, VSCP, OSIR, ALGT, CSD, UUP Are Seasonally Ripe To Go Up In the Next Five Weeks
[November 12, 2012]

CRDC, VSCP, OSIR, ALGT, CSD, UUP Are Seasonally Ripe To Go Up In the Next Five Weeks

Nov 12, 2012 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / is monitoring the Seasonality of Cardica Inc (NASDAQ:CRDC), VirtualScopics Inc (NASDAQ:VSCP), Osiris Therapeutics Inc (NASDAQ:OSIR), Allegiant Travel Co (NASDAQ:ALGT), Guggenheim Spin-Off ETF (NYSE:CSD), PowerShares DB US Dollar Index Bullish Fund (NYSE:UUP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: The following stocks are expected to go Up: Symbol Company Expected Return Odds By The Following Date CRDC Cardica Inc 6.71% 66.67% (4 of 6) Tuesday, December 4th 2012 VSCP VirtualScopics Inc 4.72% 85.71% (6 of 7) Thursday, November 15th 2012 OSIR Osiris Therapeutics Inc 10.49% 100.00% (6 of 6) Thursday, December 20th 2012 ALGT Allegiant Travel Co 9.37% 100.00% (5 of 5) Wednesday, December 19th 2012 CSD Guggenheim Spin-Off ETF 2.02% 100.00% (5 of 5) Friday, December 7th 2012 UUP PowerShares DB US Dollar Index Bullish Fund 1.17% 100.00% (5 of 5) Monday, December 3rd 2012 Cardica Inc (NASDAQ:CRDC) - Cardica, Inc. designs and manufactures medical devices for cardiac and other surgical procedures based on its proprietary stapling and cutting technology. It designs and manufactures its automated anastomosis product line, the C-Port Distal Anastomosis systems and PAS-Port Proximal Anastomosis system to automate the joining of blood vessels for the coronary artery bypass graft (CABG) surgery market. The company develops the C-Port Flex A Anastomosis system to enable automated anastomoses, or the joining of blood vessels, to be performed as part of minimally invasive and surgical robot-facilitated CABG procedures. In addition, Cardica is developing the Microcutter, a true multi-fire endoscopic stapling device designed to be used in a various procedures, including bariatric, thoracic, and general surgery. The company was founded in 1997 and is based in Redwood City, California..

VirtualScopics Inc (NASDAQ:VSCP) - VirtualScopics, Inc. provides imaging solutions for clinical trials serving the pharmaceutical, biotechnology, and medical device industries. The company offers a suite of image analysis software tools and applications, which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. Its image-based measurement and visualization tools enable automated, accurate, and reproducible measurement of changes that occur in anatomic structures in musculoskeletal, oncological, cardiological, and neurological diseases. VirtualScopics has strategic relationship with Pfizer Inc. for the discovery, validation, and application of image-based biomarkers for clinical research; with PPD Development, LP. to provide integrated clinical and medical imaging services to biopharmaceutical companies in the therapeutic areas of hematology and oncology; and with Pharmaceutical Product Development Inc. to deliver a set of clinical and medical imaging services. The company was founded in 2000 and is headquartered in Rochester, New York..

Osiris Therapeutics Inc (NASDAQ:OSIR) - Osiris Therapeutics, Inc., a stem cell therapeutic company, focuses on developing and marketing products to treat medical conditions in the inflammatory, orthopedic, and cardiovascular areas in the United States and internationally. Its lead biologic drug candidate includes Prochymal, which is in Phase 3 clinical trials for the treatment of acute and steroid refractory graft versus host disease (GvHD) and Crohn's disease, as well as for the repair of gastrointestinal injury resulting from radiation exposure. The company is also developing its Prochymal drug candidate for the repair of heart tissue following a heart attack, and for the protection of pancreatic islet cells in patients with type 1 diabetes. In addition, it is developing Chondrogen, a biologic drug candidate for the treatment of osteoarthritis and the reduction of pain in the knee. Additionally, the company focuses on developing biologic products for use in surgical procedures. The company has collaboration agreements with Genzyme Corporation for the development and commercialization of Prochymal and Chondrogen; Juvenile Diabetes Research Foundation for developing Prochymal as a treatment for the preservation of insulin production in patients with newly diagnosed type 1 diabetes; and JCR Pharmaceuticals Co., Ltd. for the distribution of Prochymal for GvHD in Japan. Osiris Therapeutics was founded in 1992 and is headquartered in Columbia, Maryland..

Allegiant Travel Co (NASDAQ:ALGT) - Allegiant Travel Company operates as a leisure travel company in the United States. The company provides scheduled passenger services from small cities to leisure destinations. It focuses on transporting travelers in small cities to leisure destinations, such as Las Vegas, Nevada; Phoenix, Arizona; Los Angeles, California; and Orlando, Tampa/St. Petersburg, and Ft. Lauderdale, Florida. The company sells air travel on a stand-alone basis, as well as bundled with hotel rooms, rental cars, and other travel related services. It also provides charter air services under long-term contracts, as well as on a seasonal and ad-hoc basis. The company markets its services through advertising and promotions in newspapers, magazines, television, and radio, as well as through targeted public relations and promotional activities. As of February 1, 2010, it operated a fleet of 46 aircraft consisting of 28 MD-83 aircraft, 4 MD-87 aircraft, 8 MD-82 aircraft, and 6 MD-88 aircraft, as well as offered scheduled service from 58 small cities on 136 routes. The company was founded in 1997 and is headquartered in Las Vegas, Nevada..

Guggenheim Spin-Off ETF (NYSE:CSD) - Claymore/Clear SpinOff ETF.

PowerShares DB US Dollar Index Bullish Fund (NYSE:UUP) - PowerShares DB US Dollar Index Bullish Fund. has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include: REGULATORY & COMPLIANCE NEWS Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

"Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO +1-800-715-9999 SqueezeTrigger is a registered trademark, Reg. No. 3,120,641 CONTACT: Thomas Ronk ((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy